Form 6-K POMDOCTOR Ltd For: Sep 30

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

For the month of September 2026

 

Commission file number: 001-42749

 

 

POMDOCTOR LIMITED

 

 

Yongxu Industrial Park
No.19-23 Hejing Road, Dongsha Street
Liwan District, Guangzhou 510000

People’s Republic of China

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒       Form 40-F ☐

 

 

 

EXHIBIT INDEX

 

Exhibit No.		Description
99.1		Press Release — POMDOCTOR LIMITED Accelerates AI-Enabled Chronic Disease Management and RWD Commercialization

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	POMDOCTOR LIMITED
	By:	/s/ Zhenyang Shi
	Name:	Zhenyang Shi
	Title:	Chairman and Chief Executive Officer

 

Date: September 30, 2026

 

 

ATTACHMENTS / EXHIBITS

PRESS RELEASE - POMDOCTOR LIMITED ACCELERATES AI-ENABLED CHRONIC DISEASE MANAGEMENT AND RWD COMMERCIALIZATION

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Semper Tax Relief Announces Structured IRS Tax Debt Resolution Process for Individuals and Small Businesses
• 2026 Rawlings Gold Glove Award® Winners Revealed
• One Stop Swap Explores School Fundraising as a Community-Based Growth Strategy